GR920100527A - Νέα ολιγοδεοξυριβονουκλεοτίδια έχοντα αντι-ισχαιμικήν δραστικότητα και μέ?οδος παραγωγής αυτών. - Google Patents

Νέα ολιγοδεοξυριβονουκλεοτίδια έχοντα αντι-ισχαιμικήν δραστικότητα και μέ?οδος παραγωγής αυτών.

Info

Publication number
GR920100527A
GR920100527A GR920100527A GR920100527A GR920100527A GR 920100527 A GR920100527 A GR 920100527A GR 920100527 A GR920100527 A GR 920100527A GR 920100527 A GR920100527 A GR 920100527A GR 920100527 A GR920100527 A GR 920100527A
Authority
GR
Greece
Prior art keywords
preparation
methods
ischemic activity
new
oligodeoxyribonucleotides
Prior art date
Application number
GR920100527A
Other languages
English (en)
Other versions
GR1002143B (en
Inventor
Armando Cedro
Ennio Lanzarotti
Marisa Mantovani
Danilo Moltrasio
Roberto Porta
Giuseppe Prino
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Publication of GR920100527A publication Critical patent/GR920100527A/el
Publication of GR1002143B publication Critical patent/GR1002143B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Η εφεύρεσις αφορά εις νέα ολιγο - δεοξυ - ριβονουκλεοτίδια ζωικής προελεύσεως, έχοντα μοριακόν βάρος μεταξύ 4000 και 10000 dalton, δυνάμενα να ληφθούν δια κλασματώσεως πολυδεοξυ - ριβονουκλεοτιδίων ή άλλως δια χημικού ή ενζυματικού αποπολυμερισμού δεοξυριβονουκλεϊκών οξέων υψηλού μοριακού βάρους. Αι νέαι ενώσεις χαίρουν σημαντικής αντι - ισχαιμικής δραστικότητας.ω
GR920100527A 1991-12-09 1992-11-26 New oligodeoxyribonucleotides having anti-ischemic activity and methods of preparation thereof. GR1002143B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI913294A IT1252174B (it) 1991-12-09 1991-12-09 Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento

Publications (2)

Publication Number Publication Date
GR920100527A true GR920100527A (el) 1994-03-31
GR1002143B GR1002143B (en) 1996-02-16

Family

ID=11361289

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920100527A GR1002143B (en) 1991-12-09 1992-11-26 New oligodeoxyribonucleotides having anti-ischemic activity and methods of preparation thereof.

Country Status (17)

Country Link
US (3) US6046172A (el)
EP (1) EP0558833A3 (el)
JP (1) JPH05247083A (el)
CN (1) CN1073448A (el)
AU (1) AU655087B2 (el)
BE (1) BE1008163A5 (el)
BR (1) BR9204931A (el)
CA (1) CA2083416A1 (el)
CH (1) CH685298A5 (el)
FR (1) FR2684675B1 (el)
GR (1) GR1002143B (el)
IL (1) IL103757A (el)
IT (1) IT1252174B (el)
LU (1) LU88197A1 (el)
MX (1) MX9207137A (el)
PT (1) PT101113A (el)
ZA (1) ZA928878B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271685B (it) * 1994-08-03 1997-06-04 Crinos Industria Farmaco Impiego dei polidesossiribonucleotidi nelle neuropati diabetiche
EP1202750A4 (en) * 1997-04-28 2002-10-16 Arsinur Burcoglu METHOD FOR THE TREATMENT OF HIV INFECTIONS AND THEIR OPPORTUNISTIC INFECTIONS
DE69928778T2 (de) * 1999-06-08 2006-07-06 Gentium S.P.A., Villa Guardia Anwendung von Komplexen von kationischen Liposomen und Polydeoxyribonukleotiden wie Arzneimitteln
MXPA05003469A (es) * 2002-10-01 2005-06-03 Truck Lite Co Faro delantero con diodo emisor de luz y montaje de faro delantero.
US7270723B2 (en) * 2003-11-07 2007-09-18 Kimberly-Clark Worldwide, Inc. Microporous breathable elastic film laminates, methods of making same, and limited use or disposable product applications
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
ITMI20050336A1 (it) * 2005-03-03 2006-09-04 Gentium Spa Formulazione ad attivita' anti-tumorale
KR20070120953A (ko) * 2005-03-03 2007-12-26 젠티엄 에스피에이 항암활성을 갖는 제제
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
US8980862B2 (en) 2010-11-12 2015-03-17 Gentium S.P.A. Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD)
CN110079580B (zh) 2012-06-22 2022-12-06 真蒂奥姆责任有限公司 用于测定去纤维蛋白多核苷酸的生物活性的基于优球蛋白的方法
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
CA3071544A1 (en) 2017-08-03 2019-02-07 Jazz Pharmaceuticals Ireland Limited Formulations comprising a nucleic acid in a high concentration
EP3773608A1 (en) 2018-04-12 2021-02-17 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
EP4110287A1 (en) 2020-02-28 2023-01-04 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
US20230086833A1 (en) 2020-04-17 2023-03-23 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
WO2022234101A1 (en) 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Defibrotide for the treatment and prevention of acute respiratory distress syndrome

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1142365B (de) * 1955-10-05 1963-01-17 Roland Vercambre Verfahren zur Gewinnung von Nucleinsaeure und deren Salze aus Fischmilch
GB808296A (en) * 1955-10-05 1959-02-04 Roland Vercambre Process for the extraction of nucleic acid and for the preparation of the salts thereof
FR1245818A (fr) * 1959-11-27 1960-10-03 Procédé de préparation d'acides désoxyribonucléiques à haut degré de polymérisation
FR1408585A (fr) * 1964-09-22 1965-08-13 Schwarz Biores Isolement et purification de bases hétérocycliques
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
JPS5217040B2 (el) * 1972-12-07 1977-05-12
SU780444A1 (ru) * 1979-06-25 1985-04-23 Специальное Конструкторско-Технологическое Бюро Биологически Активных Веществ Главного Управления Микробиологической Промышленности При Совете Министров Ссср Способ получени дезоксирибонуклеиновой кислоты
US4417046A (en) * 1981-08-24 1983-11-22 Eli Lilly And Company Process for isolating oligonucleotide product from a coupling reaction mixture
DE3308932A1 (de) * 1983-03-12 1984-09-13 Hoechst Ag, 6230 Frankfurt Verfahren zur abtrennung von ribonukleinsaeuren aus einer loesung, die desoxyribonukleinsaeuren enthaelt
SU1161511A1 (ru) * 1983-07-01 1985-06-15 Институт биоорганической химии АН БССР Способ осаждени нуклеиновых кислот из растворов,содержащих фосфатный буфер
JPS6036493A (ja) * 1983-08-08 1985-02-25 Nippon Zeon Co Ltd 保護された核酸関連物質の分離法
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
EP0290496B2 (en) * 1986-10-06 1995-12-20 The University Of Virginia Alumni Patents Foundation Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
US4833239A (en) * 1987-01-29 1989-05-23 Genetics Institute, Inc. Method for the isolation and purification of DNA molecules
US5063162A (en) * 1987-04-24 1991-11-05 Hoffmann-La Roche Inc. Process for isolating nucleic acids utilizing protease digestion
ATE104338T1 (de) * 1989-05-22 1994-04-15 Genetics Inst Verbesserte zusammensetzung zur isolierung und anreicherung von nukleinsaeure und dadurch verbessertes verfahren.
IT1232318B (it) * 1989-09-07 1992-01-28 Crinos Industria Farmaco Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.
US4997932A (en) * 1989-11-13 1991-03-05 Boehringer Mannheim Corporation Method and kit for purifying nucleic acids

Also Published As

Publication number Publication date
GR1002143B (en) 1996-02-16
IT1252174B (it) 1995-06-05
BE1008163A5 (fr) 1996-02-06
ITMI913294A0 (it) 1991-12-09
CH685298A5 (fr) 1995-05-31
US5646127A (en) 1997-07-08
FR2684675B1 (fr) 1996-10-18
ZA928878B (en) 1993-06-22
AU2968592A (en) 1993-06-10
BR9204931A (pt) 1993-06-15
CA2083416A1 (en) 1993-06-10
US6046172A (en) 2000-04-04
ITMI913294A1 (it) 1993-06-09
MX9207137A (es) 1993-08-01
EP0558833A2 (en) 1993-09-08
AU655087B2 (en) 1994-12-01
IL103757A (en) 1997-02-18
JPH05247083A (ja) 1993-09-24
FR2684675A1 (fr) 1993-06-11
US5646268A (en) 1997-07-08
CN1073448A (zh) 1993-06-23
PT101113A (pt) 1994-02-28
LU88197A1 (fr) 1993-05-17
EP0558833A3 (en) 1995-09-06

Similar Documents

Publication Publication Date Title
GR920100527A (el) Νέα ολιγοδεοξυριβονουκλεοτίδια έχοντα αντι-ισχαιμικήν δραστικότητα και μέ?οδος παραγωγής αυτών.
DE3750399D1 (de) Desinfizierende Polymerbeschichtungen für harte Oberflächen.
NO881273L (no) Molekylaere markoerer.
NO900619L (no) Substituerte 1,3-okstiolaner.
FI871768A (fi) Mjukgoerande detergentkompositioner innehaollande amidmjukgoeringsmedel.
DE69023008D1 (de) Bodenvernagelung.
DE3752041D1 (de) Nützliche, direkt wirkende Bodenbakterien
NO884333L (no) 1,4-dihydropyridiner.
DE3888530D1 (de) 3'-Azido-2',3'-dideoxynucleosid-5'-phosphonate.
ATE77200T1 (de) Insektentoetende n-substituierte-n'-substituierten,n'-diacylhydrazine.
FI883266A0 (fi) 4-aminosubstituerade 1,2-dihydronaftalenderivat.
DE3878301T2 (de) Desinfizierende polymerbeschichtungen fuer harte oberflaechen.
FI883714A (fi) Stabilisatorer foer elektrostatiska, flytande framkallare.
DE68923159D1 (de) Verfahren zur Herstellung von 1,4-Dihydropyridin-Derivaten.
FI874215A0 (fi) Polymermodifierade, omaettade polyester- eller polyesteramidhartser och ur dessa framstaelld polymerbetong.
ATE85185T1 (de) 1,4-naphthochinonderivate enthaltende rodentizide zusammensetzungen.
DE69000953T2 (de) Produkt-stabilisator.
DE69107897T2 (de) Verfahren zur Herstellung von N,N'-bis(tetrabromophthalimid).
IT8521333V0 (it) Gruccia per cravatte o analoghi articoli di abbigliamento.
DE3777600D1 (de) Substituierte 1,3,4-oxathiazol-2-one-stabilisatoren.
ATE377650T1 (de) Synthetisches nukleinsäure-partikel
FR2656608B1 (fr) Nouvelles polyamines benzoylees, leur procede de preparation et leur application comme fongicides.
IT8784142A0 (it) Impianto di termodegradazione molecolare.
NO884264D0 (no) 3'-azido-2',3'-dideoksyuridin-anti-retrovirus-blanding.
ATE55675T1 (de) Biozide-, insbesondere viruzide-, zusammensetzungen.